When adherence was measured using the MMAS-8, between-group differences in total medical, stroke-related, and bleeding-related medical costs did not reach statistical significance ( Figure 5 ).
← all excerpts
Comparison of claims vs patient-reported adherence measures and associated outcomes among patients with nonvalvular atrial fibrillation using oral anticoagulant therapy.
1
—
—